EG328644 Inhibitors
EG328644 inhibitors are a class of chemical compounds designed to specifically inhibit the activity of EG328644, a molecular target often characterized by its role in a variety of biological pathways. These inhibitors typically function by binding to the active site or allosteric sites of the target, thereby blocking its biological function. The structure of EG328644 inhibitors can vary, but they generally share a core scaffold that enables high specificity and affinity to the target protein. This core structure may be surrounded by various substituent groups, which are critical for modulating properties like solubility, permeability, and binding strength. The inhibitors' chemical structures are often optimized for maximal target engagement and stability within the cellular environment. The nature of these modifications can significantly influence the potency and selectivity of the compounds, as well as their ability to traverse cell membranes to reach intracellular targets.
Structurally, EG328644 inhibitors may exhibit diverse chemical properties, ranging from hydrophobic aromatic systems to polar functional groups that facilitate hydrogen bonding and electrostatic interactions with the target protein. These compounds are often subject to extensive structure-activity relationship (SAR) studies to enhance their inhibitory effects by refining their interaction with the binding pocket of EG328644. Such modifications can lead to variations in their binding kinetics, such as increased residence time on the target or reduced off-target effects. Furthermore, many EG328644 inhibitors undergo further chemical modifications to improve their pharmacokinetic profiles, such as enhancing metabolic stability or modulating the distribution within biological compartments. As a result, EG328644 inhibitors are of interest in biochemical and molecular biology research as tools to dissect the roles of the EG328644 protein within various pathways and cellular processes, enabling a deeper understanding of its function at a molecular level.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Oseltamivir | 196618-13-0 | sc-507283 | 100 g | $324.00 | ||
Neuraminidase inhibitor affecting sensory organs. Oseltamivir inhibits neuraminidase, potentially influencing Vwa5b2 expression through modulation of cellular processes related to sensory organ function. The indirect impact on sensory organs unravels the intricate relationship between neuraminidase activity and Vwa5b2 regulation. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
Voltage-gated calcium channel blocker affecting neural function. Nifedipine inhibits calcium channels, potentially modulating Vwa5b2 expression through calcium-dependent signaling pathways crucial for neural regulation. The direct inhibition of calcium channels sheds light on Vwa5b2's role in calcium-dependent signaling within neural tissues. | ||||||
Capsazepine | 138977-28-3 | sc-201098 sc-201098A | 5 mg 25 mg | $148.00 $459.00 | 11 | |
TRPV1 channel antagonist affecting sensory organs. Capsazepine inhibits TRPV1 channels, potentially influencing Vwa5b2 expression through modulation of sensory signaling pathways critical for sensory organ function. The direct impact on TRPV1 channels unravels the intricate relationship between sensory signaling and Vwa5b2 regulation. | ||||||
Hexamethonium bromide | 55-97-0 | sc-205712 sc-205712A | 10 g 25 g | $46.00 $64.00 | ||
Nicotinic acetylcholine receptor antagonist affecting the nervous system. Hexamethonium inhibits nicotinic receptors, potentially influencing Vwa5b2 expression through modulation of cholinergic signaling pathways. The direct inhibition of nicotinic receptors highlights Vwa5b2's involvement in cholinergic signaling crucial for neural regulation. | ||||||
Haloperidol | 52-86-8 | sc-507512 | 5 g | $190.00 | ||
Dopamine receptor antagonist impacting neurotransmission. Haloperidol inhibits dopamine receptors, potentially influencing Vwa5b2 expression in the nervous system, revealing the intricate relationship between dopamine signaling and gene regulation. The modulation of dopamine receptors provides insights into Vwa5b2's involvement in dopaminergic pathways crucial for neural regulation. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
PKC inhibitor affecting nervous system function. Bisindolylmaleimide inhibits PKC, potentially modulating Vwa5b2 expression through the intricate interplay of PKC-dependent signaling pathways crucial for neural regulation. The direct inhibition of PKC sheds light on Vwa5b2's role in PKC-dependent pathways within neural tissues. | ||||||
Propranolol | 525-66-6 | sc-507425 | 100 mg | $180.00 | ||
Adrenergic receptor antagonist affecting the nervous system. Propranolol inhibits adrenergic receptors, potentially influencing Vwa5b2 expression through modulation of adrenergic signaling pathways crucial for neural regulation. The direct inhibition of adrenergic receptors highlights Vwa5b2's involvement in adrenergic signaling within neural tissues. | ||||||
Memantine hydrochloride | 41100-52-1 | sc-203628 | 50 mg | $69.00 | 4 | |
NMDA receptor antagonist impacting neurotransmission. Memantine inhibits NMDA receptors, potentially influencing Vwa5b2 expression in the nervous system, highlighting the role of NMDA receptors in gene regulation within neural tissues. The modulation of NMDA receptors provides insights into Vwa5b2's involvement in NMDA receptor-dependent pathways crucial for neural regulation. | ||||||